Lightnews — Scholar-powered news

Genes & Diseases Journal @genesndiseases.bsky.social · 1h

This latest study shows that Yanghe Decoction suppresses #Osteosarcoma (OS) cell processes by inducing #Apoptosis, #MitochondrialDysfunction & boosting #cisplatin sensitivity, promising synergistic approaches to OS treatment. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

1 1

Reposted by Genes & Diseases Journal

European Society for Radiotherapy and Oncology (ESTRO) @estroradiotherapy.bsky.social · 2d

📢 The first-ever ESTRO Clinical Workshop is coming to Vienna | 12–13 Mar 2026! Spots are limited—don’t miss out.
📌 Submit your motivational statement by 22 Oct to secure your place.

💻 Apply now 👉 bit.ly/47wlj5G
#ESTROCLIN26 #ClinicalWorkshop #RadiationOncology

2 2

Reposted by Genes & Diseases Journal

EACR - European Association for Cancer Research @helloeacr.bsky.social · 2d

Join our free, open access webinar with the Young European Hematology Association & @yefis-immunology.bsky.social, featuring 3 presentations on CAR T-cells!

📅 19 November 14:00-15:30 CET
🌍 Zoom

us02web.zoom.us/webinar/regi...

3 2

Reposted by Genes & Diseases Journal

Precision Oncology News @preconcnews.bsky.social · 3d

The initiative comprises academic institutions, charities, and companies pursuing a broad range of novel diagnostic and therapeutic approaches.

Irish Precision Oncology Consortium Enters Second Phase With €28M

www.precisionmedicineonline.com

2 2

Genes & Diseases Journal @genesndiseases.bsky.social · 5h

This study examines how CLCA4 regulates remission and #stemness transformation in #ColorectalCancer, emphasizing that modulating stemness through CLCA4 can remodel the #TumorMicroenvironment and enhance #ClinicalOutcomes. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

Chloride channel accessory 4 suppresses stem cell-like properties of colorectal cancer and enhances anti-PD-1 immunotherapy

2

Genes & Diseases Journal @genesndiseases.bsky.social · 15h

Recent review highlights the role of the #Immunoproteasome in #Diabetes and its associated complications, positioning it a potential target for innovative therapies. #DiabetesResearch #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

1

Genes & Diseases Journal @genesndiseases.bsky.social · 1d

Latest review highlights #MitochondrialTransplantation as a novel therapeutic strategy with the potential to restore #MitochondrialDysfunction and improve #LungDisease outcomes. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

Genes & Diseases Journal @genesndiseases.bsky.social · 1d

This latest review summarises the dual roles of the #STINGPathway in #Colitis and colitis-associated #Cancer progression, providing a framework to target #Inflammation-driven #Malignancies. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

2

Reposted by Genes & Diseases Journal

ESMO - European Society for Medical Oncology @myesmo.bsky.social · 2d

👉 Showcase your rare cancer research! #ESMORareCancers26 Chairs Prof. David Thomas, Prof. Eva Tiensuu Janson & Dr. Claudia Valverde highlight why abstracts matter: visibility, expert feedback & networking.
⏰ Submit by 9 Dec 2025.
🔗 buff.ly/0MGWMsn

3 2

Reposted by Genes & Diseases Journal

Life Science Network @lifesciencenet.bsky.social · 1d

Chemists create red fluorescent dyes that may enable clearer biomedical imaging.

#science #imaging #news

www.lifescience.net/news/6600/ch...

Chemists create red fluorescent dyes that may enable clearer biomedical imaging

The new dyes are based on boron-containing molecules that were previously too unstable for practical use.

www.lifescience.net

2 2

Genes & Diseases Journal @genesndiseases.bsky.social · 1d

This review explores the roles of #PIWI and #piRNAs in #disease development, highlighting their potential as therapeutic targets. #Therapeutics #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

Genes & Diseases Journal @genesndiseases.bsky.social · 2d

This recent study reviews the role of #ACSL4 in #Ferroptosis, #OxidativeStress, & #Neuroinflammation, highlighting novel compounds that target ACSL4 and paving the way for #Clinical innovation in #AlzheimersDisease intervention. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

1

Genes & Diseases Journal @genesndiseases.bsky.social · 2d

This latest review explores the role of miR-23b in #Cancer, showing how it drives #Tumorigenesis via #Wnt/β-catenin signaling and #Apoptotic proteins such as #BCL2, positioning miR-23b as a potential target in cancer prognosis and therapy. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

Reposted by Genes & Diseases Journal

American Association for Cancer Research (AACR) @theaacr.bsky.social · 2d

The @US_FDA approved the immunotherapy cemiplimab-rwlc for adults with cutaneous squamous cell carcinoma who are at high risk for recurrence after treatment with surgery and radiation therapy: www.fda.gov/drugs/resour...

FDA approves cemiplimab-rwlc

On October 8, 2025, the Food and Drug Administration approved cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals Inc.).

www.fda.gov

1 2

Reposted by Genes & Diseases Journal

American Society of Clinical Oncology @ascocancer.bsky.social · 2d

We're bringing something new to #ASCOQLTY25! Explore advanced platforms leveraging real-world data, #AI-powered documentation & monitoring tech. in 15-minute product demos followed by Q&A.

Learn more: tinyurl.com/35yuwtv2

1 3

Reposted by Genes & Diseases Journal

ESMO - European Society for Medical Oncology @myesmo.bsky.social · 2d

🤖AI-enabled clinical trials leverage digital tools and equity-focused strategies to reach more patients, reduce disparities & improve trial representation

👉 Learn more through the word cloud in the ESMO AI & #DigitalOncology Hub: www.esmo.org/newsroom/esm...

#ESMOAI25

1 1

Genes & Diseases Journal @genesndiseases.bsky.social · 2d

The march to longevity begins with advancing ground-breaking research in #StemCell, #TissueScience, and #RegenerativeMedicine towards transforming health and extending longevity.

Inviting stem cell researchers to publish with Genes & Diseases. #ImpactFactor 9.4

#OpenAccess: buff.ly/vjl0ban

Genes & Diseases Journal @genesndiseases.bsky.social · 2d

#Hypoxia-inducible factors up-regulate #Galectin-1 via m6A-dependent ALKBH5 and YTHDF2, driving #Tumor progression in #HepatocellularCarcinoma (HCC), and opening new avenues for targeted #HCC intervention. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

Genes & Diseases Journal @genesndiseases.bsky.social · 3d

This latest review explores how expression quantitative trait loci are identified, analyzed, and tracked across different #Physiological stages and examines key data resources and their application in #Clinical #diseases. #medsky #ClinicalGenetics

#OpenAccess: www.sciencedirect.com/science/arti...

Genes & Diseases Journal @genesndiseases.bsky.social · 3d

This study reveals cell types that influence #ImmuneCheckpointInhibitor response in #HepatocellularCarcinoma & identifies potential drug candidates using bulk & single-cell sequencing, offering a roadmap for novel #Immunotherapy strategies. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

Genes & Diseases Journal @genesndiseases.bsky.social · 3d

You can now follow Genes & Diseases on YouTube.
www.youtube.com/@GenesNDisea...

Genes & Diseases Journal @genesndiseases.bsky.social · 3d

Genes & Diseases invites reviewers with expertise in:
Human genetics & genomics
Cancer biology
Neurological, cardiovascular, and metabolic disorders
Translational medicine and more
Contact us: [email protected]
#Genetics #PeerReview #GenesAndDiseases

Reposted by Genes & Diseases Journal

BioNews Central @bionewscentral.com · 3d

Scientists have developed a highly accurate #BloodTest to diagnose #ChronicFatigueSyndrome, also known as #MyalgicEncephalomyelitis (ME/CFS).
#MECFS #LongCOVID

New accurate blood test for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) unveiled – BioNews Central

Scientists have developed a highly accurate blood test to diagnose Chronic Fatigue Syndrome, also known as Myalgic Encephalomyelitis (ME/CFS). ...

sbee.link

3 3

Reposted by Genes & Diseases Journal

Precision Oncology News @preconcnews.bsky.social · 3d

The company expects top-line results in 2026 from this group of the basket trial testing the drug plixorafenib as a next-generation monotherapy.

First Interim Analysis of Fore's BRAF Inhibitor Demonstrates Preliminary Efficacy in CNS Tumors

www.precisionmedicineonline.com

1 1

Reposted by Genes & Diseases Journal

ESMO - European Society for Medical Oncology @myesmo.bsky.social · 3d

🤖 #ESMOAI25: Your not-to-miss sessions! Clinical trials for AI and AI for clinical trials, featuring discussions on applications in breast cancer, pathology and more!
⏰ Register by 22 October and benefit from advantageous fees. #HealthAI #esmomeetings

🔗 https://ow.ly/VoHA50X7yR3

1 1